Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas

Purpose Thoracic sarcomas are rare malignancies, with limited data for unresectable/advanced scenarios. Our goal is to provide insights of a three-drug chemotherapy regimen improving patient survival compared to standard regimens. Methods Retrospective cohort analysis of patients diagnosed with unre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2023-08, Vol.149 (9), p.5479-5491
Hauptverfasser:	Rodriguez-Cid, Jeronimo Rafael, Juarez-Vignon Whaley, Juan Jose, Sánchez-Domínguez, Gisela, Guzmán-Casta, Jordi, Carrasco-CaraChards, Sonia, Guzmán-Huesca, Jorge, Riera-Sala, Rodrigo, Sánchez-Ríos, Carla Paola, Cruz-Zermeño, Mayte, Seidman-Sorsby, Alec, de Jesús Rodríguez-Zea, Ivan, Alatorre-Alexander, Jorge Arturo, Martínez-Barrera, Luis Manuel, Santillán-Doherty, Patricio Javier, Godina-Flores, Aminadab, Imaz-Olguin, Victoria, Sosa-Sánchez, Ricardo, Green-Renner, Dan
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Research Carboplatin Chemotherapy Cisplatin Epirubicin Hematology Histology Ifosfamide Internal Medicine Malignancy Medicine Medicine & Public Health Multivariate analysis Oncology Platinum Sarcoma Survival Thorax
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!